US Patent Issued to UNIVERSITE DE CAEN NORMANDIE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE REGIONAL FRANCOIS BACLESSE, UNIVERSITE GRNOBLE ALPES on May 6 for "Predictive and prognostic use of a miRNA for high grade serous ovarian carcinoma therapeutic care" (French Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,750, issued on May 6, was assigned to UNIVERSITE DE CAEN NORMANDIE (Caen, France), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (Paris), CENTRE REGIONAL FRANCOIS BACLESSE (Caen, France) and UNIVERSITE GRNOBLE ALPES (Saint-Martin d'Heres, France).

"Predictive and prognostic use of a miRNA for high grade serous ovarian carcinoma therapeutic care" was invented by Nicolas Vigneron (Douvres la Delivrande, France), Christophe Denoyelle (Saint-Germain-sous-Cailly, France), Laurent Poulain (Thue et Mue, France), Jean-Paul Issartel (Saint-Egreve, France), Bernard Lambert (Cabourg, France), Matthieu Meryet-Figuiere (Caen, France), Megane Vernon (Caen, France) and Audrey Guttin ...